Hiv / Aids og kosttilskud – videnskabelig forskning

1. Akerlund B et al. Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: a double-blind, placebo-controlled trial. Eur J Clin Pharmacol 50:457-461, 1996.

2. Allavena C et al. Relationship of trace element, Immunological Markers and HIV-1 Infection Progression, Biol Trace Elem Res 47:133-138, 1995.

3. Baum MK, Mantero-Atienza E, Shor-Posner G et al. Association of Vitamin B6 Status with Parameters of Immune Function in early HIV-1 Infection. J Acquir Immune Defic Syndr 4:1122-32, 1991.

4. Baum MK, Shor-Posner G. Nutritional requirement in HIV-1 infection. AIDS 8(5):715, 1994.

5. Baum M, Cassetti L, Bonvehi P, et al. Inadequate dietary intake and altered nutrition status in early HIV-1 infection.Nutr 10:16-20, 1994.

6. Baum MR, Shorposn G, Rosner B, et al. Micronutrients and HIV-1 disease progression. AIDS 9(9): 1051-1056, 1995.

7. Baur A et al. Alpha-Lipoic Acid Is an Effective Inhibitor of Human Immuno-Defiency Virus (HIV-1) Replication, Klin Wochenschr 69: 722-724, 1991.

8. Beach RS et al. Altered folate metabolism in early HIV infection. JAMA 259(4):519, 1988.

9. Bëgin ME, Das UN. A deficiency in dietary gamma-linolenic and/or eicosapentaenoic acids may determine individual susceptibility to AIDS. Med Hypothes 20(1): 1-8, 1986.

10. Berger DS, Reiter WM, Vorce DE, et al. Prevalence of red blood cell magnesium deficiency in HIV-1 infected patients and its association with fatigue and myalgia. Abstr. J Am Coll Nutr 13(5): 522, 1994.

11. Bianchi-Santamaria A, Fedeli S, Santamaria L. Short communication: possible activity of beta-carotene in patients with the AIDS related complex (ARC). A pilot study. Med Oncol Tumor Pharmacother 9(3):151-3, 1992: Bianchi-Santamaria A et al. Possible Activity of Beta-carotene in Patients with the AIDS Related Complex (ARC). IXth Int Conf on AIDS PO-B28-2168, Berlin, 1993.

12. Boelaert JR et al. Altered iron metabolism in HIV infections: mechanisms, possible consequences, and proposals for management. Infect Agents Dis 5:36-46, 1996.

13. Bogden JD et al. Micronutrient status and human immunodeficiency virus (HIV) infection. Ann N Y Acad Sci 587:189-95, 1990.

14. Bounous G, Gold P. The biological activity of undenatured dietary whey proteins: role of glutathione. Clin Invest Med 14(4):296-309, 1991.

15. Buhl R et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet ii:1294-7, 1989.

16. Bum MK et al. Association of Vitamin B6 Status with Parameters of Immune Function in Early HIV-1 Infection. J AIDS 4:122-32, 1991.

17. Burkes RL et al. Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol 38:141-7, 1987.

18. Busse E, Zimmer G, Schopohl B, Kornhuber B. Influence of alpha-lipoic acid on intracellular glutathione in vitro and in vivo. Arzeimittelforschung 42(6):829-31, 1992.

19. Branowitz SA, Starrett B, Brookner AR. Carotene deficiency in HIV patients. AIDS 10(1):115, 1996.

20. Brighthope I. AIDS-Remissions using Nutrient Therapies and Megadose Intravenous Ascorbate. Int Clin Nutr Rev 7(2):53-75, 1987.

21. Butterworth RF et al. Thiamine deficiency in AIDS. Lett. Lancet 338:1086, 1991.

22. Casey KM, Malnutrition Associated with HIV/AIDS, Part One: Defition and Scope, Epidemiology, and Pathophysiology, J Assoc Nurses AIDS Care 8:24-32, 1997.

23. Cathcart RF 3rd. Glutathione and HIV infection. Lett. Lancet i: 235, 1990; Cathcart RF 3rd. Vitamin C in the Treatment of Acquired Immune Deficiency Syndrome (AIDS). Med Hypotheses 14(4): 423-33, 1984.

24. Chan MM, Inhibition of Tumor Necrosis Factor by Curcumin, a Phytochemical, Biochem Pharmacol 49, 11: 1551-6, 1995.

25. Cifone, M. Grazia et al. Effect of L-carnitine Treatment in Vivo on Apoptosis and Ceramide Generation in Peripheral Blood Lymphocytes from AIDS Patients. Pro Assoc Am Phys March 109(2): 146-153, 1997.

26. Constans J et al. Fatty acids and plasma antioxidants in HIV-positive patients: correlation with nutritional and immunologic status. Clin Biochem 28: 421-6, 1995.

27. Constans J, Pellegrin JL, Sergeant C, et al. Serum selenium predicts outcome in HIV infection. J AIDS Human Retrovirol 10:392, 1995.

28. Copeland R et al. Curcumin Therapy in HIV-Infected Patients. Int Conf AIDS 10:216, abstract no pb 0876, 1994.

29. Constans J et al. Serum selenium predicts outcome in HIV infection. J Acquir Immune Defic Syndr 10(3): 392, 1995.

30. Coodley GO et al. Beta-Carotene in HIV Infection. J Acquir Immune Defic Syndr 6: 272-276, 1993.

31. Coodley GO et al. Beta-Carotene in HIV Infection: An extended evaluation. AIDS 10(9): 967-73, 1996.

32. Corcoran GB, Wong BK. Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: Studies with N-acetyl-D-cysteine in mice. J Pharmacol Exp Ther 238: 54-61, 1986; Lauterburg BH et al. Mechanism of action of N-acetylcysteine in the protection against the hepatotoxicity of acetaminophen in rats in vivo. J Clin Invest 71:980-91, 1983; Mihm S et al. Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives. AIDS 5(5): 497-503, 1991.

33. Cirelli A, Ciardi M, de Simone C, et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem 24(2): 211-214, 1991.

34. Coutsoudis A, Bobat R, Coovadia H. The effects of vitamin-A supplementation on the morbidity of children born to HIV-infected women. Am J Public Health 85(8):1076-1081, 1995.

35. Davtyan DG, Vinters HV. Wernicke’s encephalopathy in AIDS patient treated with zidovudine. Letter. Lancet i:919-20, 1987; Foresti V, Confalonieri F. Wernicke’s encephalopathy in AIDS. Letter. Lancet i:1499, 1987; Lindboe CF, Loberg EM. Wernicke’s encephalopathy in non-alcoholics: an autopsy study. J Neurol Sci 90:125-9, 1989; Schwenk J et al. Wernicke’s encephalopathy in two patients with acquired immunodeficiency syndrome. J Neurol 7: 445-7, 1990.

36. Delmas-Beauvieux M-C, Peuchant E, Couchouron A, et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or carotene. Am J Clin Nutr 64: 101-107, 1996.

37. de Gordon AM. Evaluation of Tissue Zinc Status through Cell-mediated Immune Response in HIV disease. Abstract. J Am Coll Nutr 11(5): 602, 1992.

38. de Gordon AM. Effects of adjuvant therapy with zinc in human immunodeficiency infection. Abstract. J Am Coll Nutr 11(5): 601, 1992.

39. De Simone C, Famularo G, Tzantzoglou S, et al. Carnitine Depletion in peripheral blood mononuclear cells from patients with AIDS: effect of Oral L-carnitine. AIDS 8(5): 655-60, 1994; DeSimone C, Tzantzoglou S, Famularo G, et al. High dose L-carnitine Improves Immunologic and Metabolic Parameters in AIDS patients. Immunopharmacol Immunotoxicol 15(1): 1-12, 1993.

40. De Simone C, Famularo G, Tzantzoglou S, et al. Carnitine depletion in peripheral blood mononuclear cells from patients with AIDS: effect of oral L-carnitine. AIDS 8(5):655-60, 1994.

41. de Quay B, Malinverni R, Lauterburg BH. Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 6(8):815-9, 1992.

42. Di Marzio, Luisa, et al. Influence of L-carnitine on CD95 cross-linking- induced apoptosis and ceramide generation in human cell lines: correlation with its effects on purified acidic and neutral sphingomyelinases in vitro. Pro Assoc Am Phys 109(2):154-63, 1997.

43. Dowling S, Lambe J et al. Vitamin B12 and folate status in human immunodeficiency virus infection. Eur J Clin Nutr 47: 803-807, 1993.

44. Dröge W et al. Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. Biol Chem Hoppe-Seyler 369:143-8. 1988.

45. Dröge W et al. HIV-induced cysteine deficiency and T-cell dysfunction – a rationale for treatment with N-acetylcysteine. Immunology Today 13(6):211-14, 1992.

46. Dröge W. Cysteine and Glutathione Deficiency in AID Patients: a Rationale for the Treatment with N-acetyl-cysteine. Pharmacology 46(2): 61-65, 1993.

47. Dworkin BM et al. Selenium deficiency in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 10(4): 405-407, 1986.

48. Dworkin BM et al. Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res 15:167-177, 1988.

49. Dworkin BM et al. Reduced cardiac selenium content in the acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 13(6):644-647, 1989.

50. Dworkin BM. Selenium deficiency and HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Interact 91:181-6, 1994.

51. Eck HP et al. Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol Chem Hoppe Seyler 370(2):101-8, 1989.

52. Ehrenpreis E, Carlson S, Boorstein H, et al. Malabsorption and deficiency of vitamin B12 in HIV-infected patients with chronic diarrhea. Dig Dis Sci 39(10):2159-62, 1994.

53. Eylar E, et al. Sustained Levels of Ascorbic Acid Are Toxic and Immunosuppressive for Human T Cells, P R Health Sci J 15: 309-10, 1996.

54. Fabris N et al. AIDS, zinc deficiency, and thymic hormone failure. Letter. JAMA 259(6):839-40, 1988.

55. Favier A, et al. Antioxidant Status and Lipid Peroxidation in Patients Infected with HIV, Chem Biol Interact 91, 2-3:165-80, 1994.

56. Folkers K, Langsjoen P, Nara Y, et al. Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment. Biochem Biophys Res Commun 153:888-96, 1988.

57. Folkers K, Hanioka T, Xia LJ, et al. Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the AIDS-related complex. Biochem Biophys Res Commun 176(2):786-91, 1991.

58. Folkers K, Morita M, McRee Jr. J. The activities of coenzyme Q10 and vitamin B6 for immune response. Biochem Biophys Res Commun 193:88-92, 1993.

59. Fryburg DA et al. The immuno stimulatory effects and safety of Beta-carotene in patients with AIDS. VIIIth Int Conf on AIDS PoB3458, Amsterdam, 1992.

60. Fryberg DA et al. The Effect of Supplemental Beta-Carotene on Immunologic Indices in Patients with AIDS: A Pilot Study, Yale J Biol Med 68:19-23, 1995.

61. Garewal HS, Ampel N, Watson R, et al. A Preliminary Trial of Beta-carotene in subjects infected with the Human Immunodeficiency Virus. J Nutr 122: 728-732, 1992.

62. Gogu SR, Beckman BS, Rangan SRS, Agrawal KC. Increased therapeutic efficacy of zidovudine in combination with vitamin E. Biochem Biophys Res Commun 165(1):401-7, 1989.

63. Gogu SR et al. Protection of zidovudine-induced toxicity against murine erythroid progenitor cells by vitamin E. Exp Hematol 19(7):649-52, 1991.

64. Greenberg BL et al. Vitamin A of deficiency and maternal-infant transmission of HIV in two metropolitan areas in the United States. AIDS 11:325-32, 1997.

65. Han D, Tritschler JH, Packer L. Alpha-lipoic acid increases cellular glutathione in a human T-lymphocyte Jurkat cell line. Biochem Biophys Res Commun 207(1):258-64, 1995.

66. Harakeh S, Jariwalla RJ, Pauling L. Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells. Proc Natl Acad Sci U S A 87(18):7245-9, 1990.

67. Harakeh S, Jariwalla RJ. Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells. Am J Clin Nutr 54:1231S-5S, 1991.

68. Harakeh S, Jariwalla RJ. Ascorbate Effect on Cytokine Stimulation of HIV Production, Nutrition 11, Suppl. 5: 684-7, 1995.

69. Harriman GR et al. Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med 149(9): 2039-2041, 1989.

70. Hattori T et al. Preliminary Evidence for Inhibitory Effect of Glyrcyrrhizin on HIV Replication in Patients with AIDS. Antiviral Res 11: 255-261, 1989.

71. Haug S, Muller F, Aukrust P, et al. Subnormal serum concentrations of 1,25-vitamin D in human immunodeficiency virus infection: Correlation with degree of immune deficiency and survival. J Infect Dis 169:889-92, 1994.

72. Herzenberg LA, De Rosa SC, Dubs JG, et al. Glutathione deficiency is associated with impaired survival in HIV disease. Proc Natl Acad Sci USA 94:1967-72, 1997.

73. Herzlich BC et al. Synergy of inhibition of DNA synthesis in human bone marrow by azidothymidine plus deficiency of folate and/or vitamin B12? Am J Hematology 33:177-83, 1990.

74. Hu JJ et al. Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. Canc Epidemiol Biomark Preven 5(4):263-70, 1996.

75. Ikegami N et al. Clinical Evaluation of Glycyrrhyzin on HIV-Infected Asymptomatic Hemophiliac Patients in Japan. Fifth International Conference on AIDS (June 1989):Abstract W.B.P. 298; cited in AIDS Treatment News 103, 1990.

76. Ikegami N et al. Prophylactic Effect of Long-Term Oral Administration of Glycyrrhyzin on AIDS Development of Asymptomatic Patients. Int Conf AIDS 9 (1):234, abstract no PO-A25-9596, 1993.

77. Ince S. Vitamin Supplements may help delay Onset of AIDS. Medical Tribune September 9, p.18, 1993.

78. Jain VK, Chandra RK. Does nutritional deficiency predispose to Acquired Immune Deficiency Syndrome (AIDS) ? Nutr Res 4: 537-543, 1984.

79. Jariwalla RJ. Micro-nutrient imbalance in HIV infection and AIDS: relevance to pathogenesis and therapy. J Nutr Environ Med 5:297-306, 1995.

80. Jarstrand C et al. Glutathione and HIV infection. Letter. Lancet i:234-6, 1990.

81. Jolly PE, Yang Y-L, Alvarez JO, Smoot TM. Vitamin A depletion in HIV infection and AIDS. AIDS 10:114, 1995.

82. Kalebic T, Kinter A, Poli G, et al. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetyl cysteine. Proc Natl Acad Sci U S A 88:986-90, 1991.

83. Kanofsky JD et al. Is there a role for vitamin A or carotene in HIV therapy? Poster presentation at the 31st Annual Meeting, Am. College of Nutrition, October 13-15, 1990.

84. Karter DL et al. Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study. J Acquir Immune Defic Syndr Hum Retrovirol 8:199-203, 1995.

85. Kieburtz K et al. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Arch Neurol 48:312-14, 1991.

86. Koch J et al. Zinc levels and infections in hospitalized patients with AIDS. Nutrition 12(7/8):515-8, 1996.

87. Kotler DP. Management of nutritional and disease gastroenterological problems in the acquired immunodeficiency syndrome (AIDS). Abstract. J Am Coll Nutr 8(5):453, 1989.

88. Liang B et al. Vitamins and Immunomodulation in AIDS, Nutr 12:1-7, 1996.

89. Look MP et al. Serum selenium, plasma glutathione (GSH) and erythrocyte glutathione peroxidase (GSH-Px)-levels in asymptomatic versus symptomatic human immunodeficiency virus-1 (HIV-1)-infection. Eur J Clin Nutr 51:266-72, 1997.

90. Malvy DJM, Richard MJ, Arnaud J, et al. Relationship of plasma malondialdehyde, vitamin E and antioxidant micronutrients to human immunodeficiency virus. 1. Seropositivity. Clin Chim Acta 224:89-94, 1994.

91. Mastroiacovo P et al. Antioxidant Vitamins and Immunodeficiency. Int J Vitam Nutr Res 66:141-145, 1996.

92. Mazumder A et al. Inhibition of Human Immunodefiency Virus Type-1 Integrase by Curcumin. Biochemical Pharmacol 49:1165-70, 1995.

93. Mckeown LA. Beta-carotene lifts CD4 counts. Study reported in Medical Tribune Feb. 25, p. 1. 1993.

94. Mintz M. Carnitine in Human Immunodeficiency Virus type I infection/Acquired Immune Deficiency Syndrome. J Child Neurol [Canada] 10(suppl 2):315-22, 1995.

95. Mocchegiani E, Veccia S, Ancarani F, et al. Benefit of Oral Zinc supplementation as an adjunct to Zidovudine (AZT) Therapy against Opportunistic Infections in AIDS. Int J Immunopharmacol 17(9):719-27, 1995.

96. Mori K et al. Effects of Glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in Hemophelia Patients with HIV-1 Infection. Tohuko J Exp 162:183-93, 1990.

97. Moseson M et al. The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. J Acquir Immune Defic Syndr (AIDS) 2(3):235-47, 1989.

98. Noever D. Naturally Occurring Protease Inhibitors Potent against the Human. Biochemical Biophys Res Commun 227:125-30, 1996.

99. Odeh M. The role of Zinc in Acquired Immunodeficiency Syndrome. J Intern Med 231(5):463-9, 1992.

100. Odeleye OE, Watson RR. The potential role of vitamin E in the Treatment of immunologic abnormalities during Acquired Immune Deficiency Syndrome. Prog Food Nutr Sci 15(1-2):1-19, 1991.

101. Omene JA, Easington CR, Prosper M, Ledlie S. Serum Beta-carotene Deficiency in HIV-infected Children. J Natl Med Assoc 88(12):789-793, 1996.

102. Palamara AT et al. Glutathione inhibits HIV Replication by acting at late stages of the Virus Life Cycle. AIDS Res Hum Retroviruses 12(16):1537-41, 1996.

103. Palteil O et al. Clinical Correlates of Subnormal Vitamin B12 Levels in Patients Infected with the Human Immunodeficiency Virus, Am J Hematol 49:318-22, 1995.

104. Park KGM et al. Stimulation of Lymphocyte Natural Cytotoxicity by L-arginine. Lancet 337:645-6, 1991.

105. Periquet BA, Jammes NM, Lambert WE, et al. Micronutrient Levels in HIV-1-infected children. AIDS 9:887-93, 1995.

106. Phuapradit W et al. Serum vitamin A and Carotene levels in pregnant Women infected with Human Immunodeficiency Virus-1. Obstet Gynecol 87(4):564-7, 1996.

107. Rao S, Rao MNA. Curcuminoids As Potent Inhibitors of Lipid Peroxidation. J Pharm Pharmacol 46: 1013-6, 1994.

108. Razzini E, Baronzio GF. Omega-3 fatty Acids as coadjuvant treatment in AIDS. Med Hypotheses 41(4):300-5, 1993.

109. Remacha AF et al. Vitamin B-12 abnormalities in HIV-infected patients. Eur J Haematol 47:60-4, 1991.

110. Revell P et al. Folic Acid absorption in Patients infected with the Immunodeficiency Virus. J Intern Med 230:227-31, 1991.

111. Robertson KR et al. Vitamin B12 Deficiency and Nervous System Disease in HIV Infection, Arch Neurol 50:807-11, 1993.

112. Roederer M, Staal FJT, Raju PA, et al. Cytokine-stimulated Human Immunodeficiency Virus Replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci U S A 87(12): 4884-4888, 1990.

113. Roederer M, Ela SW, Staal FJ, et al. N-acetylcysteine: A new Approach to Anti-HIV Therapy. AIDS Res Hum Retroviruses 8(2): 209-217, 1992.

114. Roederer M, Staal FJ, Herzenberg LA, Herzenberg LA. N-acetylcysteine: Potential for AIDS Therapy. Pharmacology 46: 121-129, 1993.

115. Roberts RL et al. N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear cells from healthy adults in Human Immunodeficiency Virus-infected Patients. J Infect Dis 172: 1492-1502, 1995.

116. Rule SAJ et al. Serum vitamin B12 and Transcobalamin levels in early HIV Disease. Am J Hematol 47:167-71, 1994.

117. Sappey C et al. Vitamin, Trace element and Peroxide status in HIV seropositive patients: asymptomatic patients present a severe Carotene Deficiency. Clin Clim Acta 230:35-42, 1994.

118. Schrauzer GN, Sacher J. Selenium in the maintenance and Therapy of HIV-infected patients. Chem Biol Interact 91:199-205, 1994.

119. Semba R, Graham N, Caiaffa W, et al. Increased Mortality associated with Vitamin A Deficiency during Human Immunodeficiency Virus type 1 infection. Arch Intern Med 153:2149-54, 1993.

120. Semba RD, Park S, Royal W, Griffin DE. Vitamin A deficiency and T-cell subpopulation in HIV-infected adults. Nutr Res 16:915-23, 1996.

121. Semino-Mora MC et al. Effect of L-Carnitine on the Zidovidine-Induced Destruction of Human Myotubes, Lab Invest 71, 102-12, 1994.

122. Shor-Posner G, Feaster D, Blaney N, et al. Impact of Vitamin B6 Status on Psychological Distress in a longitudinal Study of HIV-1 infection. Int J Psychol Med 24(3):209-22, 1994.

123. Shor-Posner G, Miguez-Burbano MJ, Lu Y, et al. Elevated IgE levels in Relationship to nutritional Status and Immune parameters in early Human Immuno Deficiency Virus Type I Disease. J Allergy Clin Immunol 95:886-92, 1995.

124. Shor-Posner G, Morgan R, Willie F, et al. Plasma Cobalamin Levels affect information processing speed in a longitudinal study of HIV-1 Disease. Arch Neurol 52(2):195-201, 1995.

125. Singh S, Aggarwal BB. Activation of Transcription Factor NF-Kappa B Is Suppressed by Curcumin (Diferulolymethane), J Biol Chem 270, 42: 24995-5000, 1995.

126. Skurnick J.H. et al., Micronutrient Profiles in HIV-1-Infected Heterosexual Adults, J AIDS Human Retrovirol 12:75-83, 1996.

127. Smith I et al. Folate Deficiency and Demyelination in AIDS. Lancet ii:215, 1987.

128. Smith RS. Is Fish Oil protective against AIDS? J Orthomol Med 6:2, 64-6, 1991.

129. Staal FJ, et al. Glutathione Deficiency and Human Immunodeficiency Virus Infection, Lancet 339:909-12, 1992.

130. Tang A, Graham N, Kirby A, et al. Dietary micronutrient intake and the risk of progression to Acquired Immunodeficiency Syndrome (AIDS) in Human Immunodeficiency Virus Type 1 (HIV-1) infected homosexual men. Am J Epidemiol 138:937-51, 1993.

131. Tang AM, Graham NM, Saah AJ. Effects of Micronutrient Intake on Survival in Human immunodeficiency virus type 1 Infection. Am J Epidemiol 143:1244-56, 1996.

132. Tang AM, Graham NM, Chandra RK, Saah AJ. Low Serum Vitamin B-12 concentrations are associated with Faster Human Immunodeficiency Virus type 1 (HIV-1) disease progression. J Nutr 127:345-51, 1997.

133. Tang AM et al. Association between Serum Vitamin A and E levels and HIV-1 disease progression. AIDS 11:613-20, 1997.

134. Tilkian SM et al. Altered Folate Metabolism in early HIV Infection. Letter. JAMA 259:3128-9, 1988.

135. Timbo BB, Tollefson L. Nutrition: A Cofactor in HIV Disease. J Am Diet Assoc 94:1019-22, 1994.

136. Ullrich R, Schneider T, Heise W, et al. Serum Carotene Deficiency in HIV-Infected Patients. AIDS 8:661-5, 1994.

137. Valesini G et al. A Calf Thymus Lysate Improves Clinical Symptoms and T-Cell Defects in the Early Stages of HIV Infection: Second Report, Eur J Cancer Clin Oncol 23: 1915-9, 1987.

138. Varela P, Marcos A, Ripoll S, et al. Effects of human immunodeficiency virus infection and detoxification time on anthropometric measurements and dietary intake of male drug addicts. Am J Clin Nutr 66:509S-14S, 1997.

139. Wang Y, Watson RR. Potential Therapeutics of Vitamin E (Tocopherol) in AIDS and HIV, Drugs 48:327-38, 1994.

140. Ward BJ, Humphrey JH, Clement L, Chaisson RE. Vitamin A status in HIV infection. Nutr Res 13:157-66, 1993.

141. Waterson SK. Glutathione deficiency: Therapeutic target in Human Immunodeficiency Virus Infection. J Orthomol Med 7(2):104-10, 1992.

142. Wu J, Levy EM, Black PH. 2-mercaptoethanol and N-acetylcysteine enhance T cell colony formation in AIDS and ARC. Clin Exp Immunol 77:7-10, 1989.

143. Zazzo JF, Chalas J, Lafont A, et al. Is nonobstructive cardiomyopathy in AIDS a selenium deficiency-related disease? Lett. JPEN J Parenter Enteral Nutr 12(5):537-8, 1988.